Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial

CONCLUSIONS: The trial demonstrated that hydrogen/oxygen therapy is superior to oxygen therapy in patient with AECOPD with acceptable safety and tolerability profile.TRIAL REGISTRATION: Name of the registry: U.S National Library of Medicine Clinical Trials; Trial registration number: NCT04000451; Date of registration: June 27, 2019-Retrospectively registered; URL of trial registry record: https://www.clinicaltrials.gov/ct2/show/study/NCT04000451?term=04000451&draw=2&rank=1 .PMID:33985501 | DOI:10.1186/s12931-021-01740-w

Source: Respiratory Care - May 14, 2021 Category: Respiratory Medicine Authors: Ze-Guang Zheng Wu-Zhuang Sun Jie-Ying Hu Zhi-Jun Jie Jin-Fu Xu Jie Cao Yuan-Lin Song Chang-Hui Wang Jing Wang Hui Zhao Zhong-Liang Guo Nan-Shan Zhong Source Type: research